Bank Of America Corp Brainstorm Cell Therapeutics Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,607 shares of BCLI stock, worth $2,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,607

Previous 1,492 7.71%

Holding current value

$2,281

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.22 - $0.42 $25 - $48	115 Added 7.71%	1,607 $0
Q2 2024 Aug 14, 2024	BUY	$0.34 - $0.74 $167 - $364	492 Added 49.2%	1,492 $0
Q1 2024 May 15, 2024	SELL	$0.28 - $0.66 $15 - $35	-54 Reduced 5.12%	1,000 $0
Q4 2023 Feb 14, 2024	SELL	$0.15 - $0.4 $618 - $1,650	-4,125 Reduced 79.65%	1,054 $0
Q2 2023 Aug 14, 2023	BUY	$2.0 - $3.2 $654 - $1,046	327 Added 6.74%	5,179 $10,000
Q1 2023 May 12, 2023	SELL	$1.43 - $3.3 $1,399 - $3,230	-979 Reduced 16.79%	4,852 $16,000
Q4 2022 Feb 10, 2023	BUY	$1.37 - $4.42 $584 - $1,887	427 Added 7.9%	5,831 $9,000
Q3 2022 Nov 14, 2022	SELL	$2.55 - $4.42 $5,627 - $9,754	-2,207 Reduced 29.0%	5,404 $23,000
Q2 2022 Aug 12, 2022	BUY	$2.71 - $3.6 $1,054 - $1,400	389 Added 5.39%	7,611 $21,000
Q1 2022 May 16, 2022	BUY	$2.92 - $4.19 $12,059 - $17,304	4,130 Added 133.57%	7,222 $24,000
Q4 2021 Feb 08, 2022	SELL	$2.81 - $4.23 $24,264 - $36,526	-8,635 Reduced 73.63%	3,092 $12,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $4.09 $77,209 - $100,569	-24,589 Reduced 67.71%	11,727 $38,000
Q2 2021 Sep 13, 2021	BUY	$3.01 - $4.01 $109,311 - $145,627	36,316 New	36,316 $138,000

Others Institutions Holding BCLI

# of Institutions

Shares Held

10.8M

Call Options Held

160K

Put Options Held

30.5K

View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $51.8M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

More about BCLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Brainstorm Cell Therapeutics Inc. Transaction History